About this test
Tests MLH1 promoter methylation in tumours that have lost MLH1 expression. Methylation points to a sporadic cancer rather than Lynch syndrome.
- Clinical area
- Molecular oncology
- Method
- Methylation analysis
- Sample
- FFPE tissue block
- Report languages
- EN · AR · RU
When to order
MSI-high or MLH1-deficient colorectal or endometrial cancer.
Results are reported to the ordering physician and should be interpreted in clinical context.
Request this test
Offer this test to your patients.
Contract pricing and turnaround times are provided on request for laboratories and clinics.
Molecular oncology